White House Leverages Old Tweet to Support Trump’s Autism Claims
URGENT UPDATE: The White House has sparked controversy by using a **six-year-old** tweet from Tylenol to support **Donald Trump’s** recent assertions linking Tylenol use during pregnancy to autism. On **Wednesday**, an administration official shared a **2017** post from Tylenol’s X account, which stated, “We actually don’t recommend using any of our products while pregnant.” This move has reignited debates and raised concerns among health professionals.
Trump’s comments during a press conference on **Tuesday**, where he urged pregnant women to avoid Tylenol, have stirred significant backlash. “With Tylenol, don’t take it. Don’t take it,” Trump declared, prompting a wave of responses from both supporters and critics online. The post shared by the White House featured a photo of Trump with a cap reading, “Trump was right about everything,” which quickly gained traction across MAGA channels.
IMMEDIATE IMPACT: Trump’s claims have sparked a fierce debate, with **U.S. Senator Bill Cassidy**, a physician, immediately countering the president’s assertions via X. Cassidy stated, “The preponderance of evidence shows that this is not the case,” urging the Department of Health and Human Services to release supporting data. Experts are alarmed, fearing Trump’s statements could mislead the public about medication safety during pregnancy.
Health research has consistently shown that **acetaminophen**, the active ingredient in Tylenol, is one of the safest options for pain relief during pregnancy. The **American College of Obstetricians and Gynecologists** has endorsed its use for treating mild to moderate pain and fever in pregnant women. However, Trump and his advisors maintain that there are alarming links between acetaminophen and rising autism rates.
Researcher **Ann Bauer**, whose work has been cited by the White House, expressed her distress over the misrepresentation of her findings. “I am sick to my stomach that RFK Jr. would link my work to discredited theories about autism,” she lamented to KFF Health News.
Moreover, **Kenvue**, the maker of Tylenol, reiterated their stance on the safety of acetaminophen, stating, “We strongly disagree with any suggestion otherwise.” The company has pointed to extensive scientific evidence showing no causal relationship between its product and autism.
As this story develops, the implications of Trump’s statements are significant for public health messaging and pregnant women’s choices. The backlash against the White House’s revival of the **2017** tweet highlights the power of misinformation in shaping health perceptions.
WHAT’S NEXT: Authorities are now calling for clearer communication from health officials regarding medication safety. The debate surrounding Tylenol use and autism is expected to intensify, with many emphasizing the need for accurate information to protect public health. Stay tuned for further updates as more information becomes available.
